Arvinas, Inc. Gains 95.06%

Mon, Dec 14, 2020 at 05:33 PM
Arvinas, Inc. Gains 95.06%

Arvinas, Inc. (ARVN:NASDAQ) soared at $58.38, representing a gain of 95.1%. On Fri 11 Dec 20, ARVN:NASDAQ hit a New 2-Week High of $29.93. The stock got featured on our News Catalysts scanner on Mon 14 Dec 20 at 04:54 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 70.00% Up Days and 72.73% Green Days

The share price of the company has been moving sideways in recent weeks.

About Arvinas, Inc. (ARVN:NASDAQ)

Arvinas Inc, formerly Arvinas Holding Co LLC is a private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The company's proprietary PROTAC protein degraders, or Proteolysis-Targeting Chimera, work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.